A systematic review of strategies to improve appropriate use of opioids and to reduce opioid use disorder and deaths from prescription opioids

References

• Dowell D , Haegerich TM , Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315(15):1624–1645. doi:10.1001/jama.2016.1464.
   Google Scholar
• Public Health Agency of Canada . Statement from the co-chairs of the federal, provincial and territorial special advisory committee on the epidemic of opioid overdoses; 2017 [accessed 2017 Nov 27]. https://www.canada.ca/en/publichealth/news/2017/09/statement_from_theco-chairsofthefederalprovincialandterritorials.html.
   Google Scholar
• Public Health Agency of Canada . Statement from the co-chairs of special advisory committee on the epidemic of opioid overdoses on updates to opioid-related mortality data; 2017 Dec 18 [accessed 2017 Dec 30]. http://www.newswire.ca/news-releases/statement-from-the-co-chairs-of-special-advisory-committee-on-the-epidemic-of-opioid-overdoses-on-updates-to-opioid-related-mortality-data-664993543.html.
   Google Scholar
• Canadian Institute for Health Information . Pan-Canadian trends in the prescribing of opioids, 2012 to 2016. 2017 [accessed 2017 Dec 26]. https://www.cihi.ca/sites/default/files/document/pan-canadian-trends-opioid-prescribing-2017-en-web.pdf.
   Google Scholar
• Canadian Pain Society . Position statement on opioid analgesics in pain management—2015 update. Pain Res Manag. 2015;20(6):287. doi:10.1155/2015/251464.
   Google Scholar
• Lynch ME , Fischer B. Prescription opioid abuse: what is the real problem and how do we fix it? Can Fam Physician. 2011;57:1241–1242, e403–e405.
   Google Scholar
• Finestone HM , Juurlink DN , Power B , Gomes T , Pimlott N. Opioid prescribing is a surrogate for inadequate pain management resources. Can Fam Physician. 2016;62:465–468.
   Google Scholar
• Lagisetty P , Klasa K , Bush C , Heisler M , Chopra V , Bohnert A . Primary care models for treating opioid use disorders: what actually works? A systematic review. PLoS One. 2017;12(10):e0186315. doi:10.1371/journal.pone.0186315.
   Google Scholar
• Saulle R , Vecchi S , Gowing L . Supervised dosing with a long-acting opioid medication in the management of opioid dependence. Cochrane Database Syst Rev. 2017;4:CD011983.
   Google Scholar
• McDonald R , Strang J . Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction. 2016;111(7):1177–1187. doi:10.1111/add.v111.7.
   Google Scholar
• Mueller SR , Walley AY , Calcaterra SL , Glanz JM , Binswanger IA . A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice. Subst Abuse. 2015;36(2):240–253. doi:10.1080/08897077.2015.1010032.
   Google Scholar
• Giglio RE , Li G , DiMaggio CJ . Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis. Inj Epidemiol. 2015;2(1):10. doi:10.1186/s40621-015-0041-8.
   Google Scholar
• Clark AK , Wilder CM , Winstanley EL . A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med. 2014;8(3):153–163. doi:10.1097/ADM.0000000000000034.
   Google Scholar
• Starrels JL , Becker WC , Alford DP , Kapoor A , Williams AR , Turner BJ . Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010;152(11):712–720. doi:10.7326/0003-4819-152-11-201006010-00004.
   Google Scholar
• Argoff CE , Kahan M , Sellers EM . Preventing and managing aberrant drug-related behavior in primary care: systematic review of outcomes evidence. J Opioid Manag. 2014;10(2):119–134. doi:10.5055/jom.2014.0201.
   Google Scholar
• Beaudoin FL , Banerjee GN , Mello MJ . State-level and system-level opioid prescribing policies: the impact on provider practices and overdose deaths, a systematic review. J Opioid Manag. 2016;12(2):109–118. doi:10.5055/jom.2016.0322.
   Google Scholar
• Furlan A , Irvin E , Van Eerd D , Carnide N, Munhall C, Kim J, Mahood, MacDonald S. Strategies to support the appropriate use of prescription opioids: a systematic review using narrative and best evidence synthesis methods. PROSPERO. 2014;CRD42014009675. http://www.crd.york.ac.uk/PROSPERO_REBRANDING/display_record.asp?ID=CRD42014009675.
   Google Scholar
• Substance Abuse and Mental Health Services Administration . Results from the 2016 national survey on drug use and health: detailed tables. 2017 [accessed 2018 Mar 7]. https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.htm.
   Google Scholar
• Dhalla IA , Mamdani MM , Sivilotti ML , Kopp A , Qureshi O , Juurlink DN . Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ. 2009;181(12):891–896. doi:10.1503/cmaj.090784.
   Google Scholar
• Rudd RA , Aleshire N , Zibbell JE , Gladden RM . Increases in drug and opioid overdose deaths—United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2016;64(50–51):1378–1382. doi:10.15585/mmwr.mm6450a3.
   Google Scholar
• Hodgson A , Normandin S . Grey matters! Finding grey literature. Ottawa (Canada): Canadian Agency for Drugs and Technologies in Health; 2008.
   Google Scholar
• Review manager (RevMan) [Computer program]. Version 5.3. Copenhagen (Denmark): The Nordic Cochrane Centre: The Cochrane Collaboration; 2014. https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=9675
   Google Scholar
• Borenstein M . Effect sizes based on means. Introduction to meta-analysis. Hoboken, NJ: John Wiley & Sons; 2009. p. 21–32.
   Google Scholar
• Rosenthal R . Meta-analytic procedures for social research. Newbury Park (CA): Sage; 1991.
   Google Scholar
• Rosenthal R . Parametric measures of effect size. In: Cooper H , Hedges LV , editors. The hand-book of research synthesis. New York (NY): Sage; 1994. p. 231–244.
   Google Scholar
• Rosnow RL . Effect sizes for experimenting psychologists. Can J Exp Psychol. 2003;57(3):221–237. doi:10.1037/h0087427.
   Google Scholar
• Hedges LV , Olkin I . Statistical methods for meta-analysis. 1st ed. San Diego (CA): Academic Press; 1985.
   Google Scholar
• Glass G , Smith ML , McGaw B . Meta-analysis in social research. Bevery Hills (CA): Sage; 1981.
   Google Scholar
• Borenstein M . Converting among effect sizes. Introduction to meta-analysis. Hoboken, NJ: John Wiley & Sons; 2009. p. 45–49.
   Google Scholar
• Cohen J . Statistical power analysis for the behavioural sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum; 1988.
   Google Scholar
• Gonzalez AM III , Kolbasovsky A . Impact of a managed controlled-opioid prescription monitoring program on care coordination. Am J Manag Care. 2012;18:516–524.
   Google Scholar
• Jamison RN , Ross EL , Michna E , Chen LQ , Holcomb C , Wasan AD . Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial. Pain. 2010;150(3):390–400. doi:10.1016/j.pain.2010.02.033.
   Google Scholar
• Naliboff BD , Wu SM , Schieffer B , Bolus R, Pham Q, Baria A, Aragaki D, Van Vort W, Davis F, Shekelle P. A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain. J Pain. 2011;12(2):288–296. doi:10.1016/j.jpain.2010.09.003.
   Google Scholar
• Otto C , Crackau B , Löhrmann I , Zahradnik A, Bischof G, John U, Rumpf HJ. Brief intervention in general hospital for problematic prescription drug use: 12-month outcome. Drug Alcohol Depend. 2009;105(3):221–226. doi:10.1016/j.drugalcdep.2009.07.010.
   Google Scholar
• Saitz R , Palfai TP , Cheng DM , Alford DP, Bernstein JA, Lloyd-Travaglini CA, Meli SM, Chaisson CE, Samet JH. Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial. JAMA. 2014;312(5):502–513. doi:10.1001/jama.2014.7862.
   Google Scholar
• Spoth R , Redmond C , Clair S , Shin C , Greenberg M , Feinberg M . Preventing substance misuse through community–university partnerships: randomized controlled trial outcomes 4 1/2 years past baseline. Am J Prev Med. 2011;40(4):440–447. doi:10.1016/j.amepre.2010.12.012.
   Google Scholar
• Spoth R , Trudeau L , Shin C , Ralston E, Redmond C, Greenberg M, Feinberg M. Longitudinal effects of universal preventive intervention on prescription drug misuse: three randomized controlled trials with late adolescents and young adults. Am J Public Health. 2013;103(4):665–672. doi:10.2105/AJPH.2012.301209.
   Google Scholar
• Spoth R , Trudeau L , Shin C , Redmond C . Long-term effects of universal preventive interventions on prescription drug misuse. Addiction. 2008;103(7):1160–1168. doi:10.1111/j.1360-0443.2008.02160.x.
   Google Scholar
• Sullivan MD , Leigh J , Gaster B . Brief report: training internists in shared decision making about chronic opioid treatment for noncancer pain. J Gen Intern Med. 2006;21(4):360–362. doi:10.1111/j.1525-1497.2006.00352.x.
   Google Scholar
• Ablaihed L , Barrueto J , Pimentel L , Comer A , Browne BJ , Hirshon JM . High risk care plans effectively decrease emergency department resource utilization. Ann Emerg Med. 2014;64(4 Suppl. 1):S4. doi:10.1016/j.annemergmed.2014.07.033.
   Google Scholar
• Albert S , Brason FW II , Sanford CK , Dasgupta N , Graham J , Lovette B . Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med. 2011;12(Suppl, 2):S77–S85. doi:10.1111/j.1526-4637.2011.01128.x.
   Google Scholar
• Andrews LB , Bridgeman MB , Dalal KS , Abazia D, Lau C, Goldsmith DF, John DS. Implementation of a pharmacist-driven pain management consultation service for hospitalised adults with a history of substance abuse. Int J Clin Pract. 2013;67(12):1342–1349. doi:10.1111/ijcp.12311.
   Google Scholar
• Barry DT , Cutter CJ , Beitel M , Liong C , Schottenfeld RS . Cognitive-behavioral therapy and educational counseling for chronic pain and opioid dependence. Drug Alcohol Depend. 2015;146:e218–e219.
   Google Scholar
• Bujold E , Huff J , Staton EW , Pace WD . Improving use of narcotics for nonmalignant chronic pain: a lesson from Community Care of North Carolina. J Opioid Manag. 2012;8(6):363–367. doi:10.5055/jom.
   Google Scholar
• Burchman SL , Pagel PS . Implementation of a formal treatment agreement for outpatient management of chronic nonmalignant pain with opioid analgesics. J Pain Symptom Manage. 1995;10(7):556–563. doi:10.1016/0885-3924(95)00085-D.
   Google Scholar
• Chelminski PR , Ives TJ , Felix KM , Prakken SD, Miller TM, Perhac JS, Malone RM, Bryant ME, DeWalt DA, Pignone MP. A primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidity. BMC Health Serv Res. 2005;5(1):3. doi:10.1186/1472-6963-5-3.
   Google Scholar
• Cicero TJ , Inciardi JA , Adams EH , Geller A, Senay EC, Woody GE, Muñoz A. Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994–2004. Pharmacoepidemiol Drug Saf. 2005;14(12):851–859. doi:10.1002/pds.1113.
   Google Scholar
• Cochella S , Bateman K . Provider detailing: an intervention to decrease prescription opioid deaths in Utah. Pain Med. 2011;12(Suppl. 2):S73–S76. doi:10.1111/j.1526-4637.2011.01125.x.
   Google Scholar
• Davis C , Walley A , Bridger C . Lessons learned from the expansion of naloxone access in Massachusetts and North Carolina. J Law Med Ethics. 2015;43(1):19–22. doi:10.1111/jlme.12208.
   Google Scholar
• Delcher C , Wagenaar AC , Goldberger BA , Cook RL , Maldonado-Molina MM . Abrupt decline in oxycodone-caused mortality after implementation of Florida’s Prescription Drug Monitoring Program. Drug Alcohol Depend. 2015;150:63–68. doi:10.1016/j.drugalcdep.2015.02.010.
   Google Scholar
• DiPaula BA , Menachery E . Physician–pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients. J Am Pharm Assoc (2003). 2015;55(2):187–192. doi:10.1331/JAPhA.2015.14177.
   Google Scholar
• Doe-Simkins M , Quinn E , Xuan Z , Sorensen-Alawad A, Hackman H, Ozonoff A, Walley AY. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study. BMC Public Health. 2014;14:297. doi:10.1186/1471-2458-14-297.
   Google Scholar
• Doe-Simkins M , Walley AY , Epstein A , Moyer P . Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health. 2009;99(5):788–791. doi:10.2105/AJPH.2008.146647.
   Google Scholar
• Dormuth CR , Miller TA , Huang A , Mamdani MM , Juurlink DN . Effect of a centralized prescription network on inappropriate prescriptions for opioid analgesics and benzodiazepines. CMAJ. 2012;184(16):E852–E856. doi:10.1503/cmaj.120465.
   Google Scholar
• Dwyer K , Walley AY , Langlois BK, Mitchell PM, Lin SC, Nelson KP, Cromwell J, Bernstein E. Opioid education and nasal naloxone rescue kitsin the emergency department. Western Journal of Emergency Medicine . 2015 May; 16(3):381–384.
   Google Scholar
• Franklin GM , Mai J , Turner J , Sullivan M , Wickizer T , Fulton-Kehoe D . Bending the prescription opioid dosing and mortality curves: impact of the Washington State opioid dosing guideline. Am J Ind Med. 2012;55(4):325–331. doi:10.1002/ajim.v55.4.
   Google Scholar
• Fulton-Kehoe D , Sullivan MD , Turner JA , Garg RK, Bauer AM, Wickizer TM, Franklin GM. Opioid poisonings in Washington state medicaid: Trends, dosing, and guidelines. Medical care. 2015;53(8): 679–685.
   Google Scholar
• Furlan AD , MacDougall P , Pellerin D , Shaw K, Spitzig D, Wilson G, Wright J. Overview of four prescription monitoring/review programs in Canada. Pain Res Manag. 2014;19(2):102–106. doi:10.1155/2014/634171.
   Google Scholar
• Garcia MM , Angelini MC , Thomas T , Lenz K , Jeffrey P . Implementation of an opioid management initiative by a state Medicaid program. J Manag Care Spec Pharm. 2014;20(5):447–454. doi:10.18553/jmcp.2014.20.5.447.
   Google Scholar
• Gaston RL , Best D , Manning V , Day E . Can we prevent drug related deaths by training opioid users to recognise and manage overdoses? Harm Reduct J. 2009;6:26. doi:10.1186/1477-7517-6-26.
   Google Scholar
• Goldberg KC , Simel DL , Oddone EZ . Effect of an opioid management system on opioid prescribing and unscheduled visits in a large primary care clinic. J Clin Outcomes Manag. 2005;12:621–628.
   Google Scholar
• Gray J , Hagemeier N , Brooks B , Alamian A . Prescription disposal practices: a 2-year ecological study of drug drop box donations in Appalachia. Am J Public Health. 2015;105(9):e89–e94. doi:10.2105/AJPH.2015.302689.
   Google Scholar
• Green TC , Dauria EF , Bratberg J , Davis CS , Walley AY . Orienting patients to greater opioid safety: models of community pharmacy-based naloxone. Harm Reduct J. 2015;12:Art–9.
   Google Scholar
• Green TC , Mann MR , Bowman SE , Zaller N, Soto X, Gadea J, Cordy C, Kelly P, Friedmann PD. How does use of a prescription monitoring program change pharmacy practice? J Am Pharm Assoc. 2013;53(3):273–381. doi:10.1331/JAPhA.2013.12094.
   Google Scholar
• Gugelmann H , Shofer FS , Meisel ZF , Perrone J . Multidisciplinary intervention decreases the use of opioid medication discharge packs from 2 urban EDs. Am J Emerg Med. 2013;31(9):1343–1348. doi:10.1016/j.ajem.2013.06.002.
   Google Scholar
• Husk G , Nguyen T , Jellinek-Cohen S , Li M , Heller M . The effect of a statewide prescription monitoring program on ed prescribing of controlled substances. Acad Emerg Med. 2014;21:S310.
   Google Scholar
• James J , Klein JW , Chew L , Merrill J , Jackson SL . A comprehensive clinic-based strategy to promote safe opioid prescribing for chronic non-cancer pain in the primary care setting. J Gen Intern Med. 2014;29:S472.
   Google Scholar
• Johnson H , Paulozzi L , Porucznik C , Mack K , Herter B . Decline in drug overdose deaths after state policy changes—Florida, 2010–2012. MMWR Morb Mort Wkly Rep. 2014;63:569–574.
   Google Scholar
• Kanate D , Folk D , Cirone S , Gordon J, Kirlew M, Veale T, Bocking N, Rea S, Kelly L. Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine–naloxone substitution therapy in the context of a First Nations healing program. Can Fam Physician. 2015;61(2):160–165.
   Google Scholar
• Katzman J , Comerci GD , Landen M , Loring L, Jenkusky SM, Arora S, Kalishman S, Marr L, Camarata C, Duhigg D. Rules and values: a coordinated regulatory and educational approach to the public health crises of chronic pain and addiction. Am J Public Health. 2014;104(8):1356–1362. doi:10.2105/AJPH.2014.301881.
   Google Scholar
• Keast SL , Nesser N , Farmer K . Strategies aimed at controlling misuse and abuse of opioid prescription medications in a state Medicaid program: a policymaker’s perspective. Am J Drug Alcohol Abuse. 2015;41(1):1–6. doi:10.3109/00952990.2014.988339.
   Google Scholar
• Ketcham EM , Fredella A , Malone M , Ketcham C , Larkin GL . A novel Six-Sigma-based multidisciplinary administrative intervention reduces opioid-seeking patient emergency department recidivism. Ann Emerg Med. 2014;64(4 Suppl. 1):S99. doi:10.1016/j.annemergmed.2014.07.306.
   Google Scholar
• Kim E , Genes N , Coupet M . Effect of mandatory prescription drug monitoring program on emergency department prescribing of scheduled drugs. Ann Emerg Med. 2014;64(4 Suppl. 1):S81–S82. doi:10.1016/j.annemergmed.2014.07.254.
   Google Scholar
• Lamb L , Pereira JX , Shir Y . Nurse case management program of chronic pain patients treated with methadone. Pain Manag Nurs. 2007;8(3):130–138. doi:10.1016/j.pmn.2007.05.002.
   Google Scholar
• Larochelle MR , Zhang F , Ross-Degnan D , Wharam JF . Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene. JAMA Intern Med. 2015;175(6):978–987. doi:10.1001/jamainternmed.2015.0914.
   Google Scholar
• Leece P , Hopkins S , Marshall C , Orkin A , Gassanov M , Shahin R . Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario. Can J Public Health. 2013;104(3):e200–e204. doi:10.17269/cjph.104.3788.
   Google Scholar
• Lofwall MR , Wunsch MJ , Nuzzo PA , Walsh SL . Efficacy of continuing medical education to reduce the risk of buprenorphine diversion. J Subst Abuse Treat. 2011;41(3):321–329. doi:10.1016/j.jsat.2011.04.008.
   Google Scholar
• Manchikanti L , Manchukonda R , Damron KS , Brandon D , McManus CD , Cash K . Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician. 2006;9:57–60.
   Google Scholar
• McCarty D , Rieckmann T , Green C , Gallon S , Knudsen J . Training rural practitioners to use buprenorphine: using the Change Book to facilitate technology transfer. J Subst Abuse Treat. 2004;26(3):203–208. doi:10.1016/S0740-5472(03)00247-2.
   Google Scholar
• Pade PA , Cardon KE , Hoffman RM , Geppert CMA . Prescription opioid abuse, chronic pain, and primary care: a co-occurring disorders clinic in the chronic disease model. J Subst Abuse Treat. 2012;43(4):446–450. doi:10.1016/j.jsat.2012.08.010.
   Google Scholar
• Paone D , Tuazon E , Kattan J , Nolan ML, O'Brien DB, Dowell D, Farley TA, Kunins HV. Decrease in rate of opioid analgesic overdose deaths—Staten Island, New York City, 2011–2013. MMWR Morb Mortal Wkly Rep. 2015;64(18):491–494.
   Google Scholar
• Piper TM , Rudenstine S , Stancliff S , Sherman S, Nandi V, Clear A, Galea S. Overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in New York City. Harm Reduct J. 2007;4:3. doi:10.1186/1477-7517-4-3.
   Google Scholar
• Reifler LM , Droz D , Bailey JE , Schnoll SH, Fant R, Dart RC, Bucher Bartelson B. Do prescription monitoring programs impact state trends in opioid abuse/misuse? Pain Med. 2012;13(3):434–442. doi:10.1111/j.1526-4637.2012.01327.x.
   Google Scholar
• Ringwalt C , Garrettson M , Alexandridis A . The effects of North Carolina’s prescription drug monitoring program on the prescribing behaviors of the state’s providers. J Prim Prev. 2015;36(2):131–137. doi:10.1007/s10935-014-0381-0.
   Google Scholar
• Saenger M , Duva IM , Abraham C , Porter R , D’Antignac V . Inter-professional “community of practice” to implement “universal precautions” for opioid safety within the patient centered medical home. J Gen Intern Med. 2013;28:S440–S441.
   Google Scholar
• Sandoo VW , Mcaughtry P , Al-Hadad A , Mavani F , Zheng T , Conroy S . Stop start tool for improving prescribing amongst older inpatients: results from a three year audit cycle. Age Ageing. 2011;40:ii25.
   Google Scholar
• Schlicher N . Reforming emergency care: experts put focus on value, better alignment. ED Manag. 2015;27:73–79.
   Google Scholar
• Srivastava A , Kahan M , Jiwa A . Prescription opioid use and misuse: piloting an educational strategy for rural primary care physicians. Can Fam Physician. 2012;58:e210–e216.
   Google Scholar
• Stover H . Barriers to opioid substitution treatment access, entry and retention: a survey of opioid users, patients in treatment, and treating and non-treating physicians. Eur Addict Res. 2010;17(1):44–54. doi:10.1159/000320576.
   Google Scholar
• Summers P , Martin C , Quidgley-Nevares A . The impact of an educational group session on opioid treatment agreement violations. J Pain. 2014;15(Suppl 2):S40.
   Google Scholar
• Taylor SE , Braitberg G , Lugt J . Multifaceted education initiative minimizes pethidine prescribing in the emergency department. Emerg Med Australas. 2007;19(1):25–30. doi:10.1111/emm.2007.19.issue-1.
   Google Scholar
• Thomas CP , Kim M , Kelleher SJ , Nikitin RV, Kreiner PW, McDonald A, Carrow GM. Early experience with electronic prescribing of controlled substances in a community setting. J Am Med Inform Assoc. 2013;20(e1):e44–e51. doi:10.1136/amiajnl-2012-001499.
   Google Scholar
• Walley AY , Xuan Z , Hackman HH , Quinn E, Doe-Simkins M, Sorensen-Alawad A, Ruiz S, Ozonoff A. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174. doi:10.1136/bmj.f174.
   Google Scholar
• Wheeler E , Davidson PJ , Stephen Jones T , Irwin KS . Community-based opioid overdose prevention programs providing naloxone—United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61:101–105.
   Google Scholar
• Wiedemer NL , Harden PS , Arndt IO , Gallagher RM . The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med. 2007;8(7):573–584. doi:10.1111/j.1526-4637.2006.00254.x.
   Google Scholar
• Kunins HV . Abuse-deterrent opioid formulations: part of a public health strategy to reverse the opioid epidemic. JAMA Intern Med. 2015;175(6):987–988. doi:10.1001/jamainternmed.2015.0939.
   Google Scholar
• Zahradnik A , Otto C , Crackau B , Löhrmann I, Bischof G, John U, Rumpf HJ. Randomized controlled trial of a brief intervention for problematic prescription drug use in non-treatment-seeking patients. Addiction. 2009;104(1):109–117. doi:10.1111/j.1360-0443.2008.02421.x.
   Google Scholar
• Fischer B , Jones W , Murphy Y , Ialomiteanu A , Rehm J . Recent developments in prescription opioid-related dispensing and harm indicators in Ontario, Canada. Pain Physician. 2015;18:E659–E662.
   Google Scholar
• Hawk KF , Vaca FE , D’Onofrio G . Reducing fatal opioid overdose: prevention, treatment and harm reduction strategies. Yale J Biol Med. 2015;88:235–245.
   Google Scholar
• Nadelmann E , LaSalle L . Two steps forward, one step back: current harm reduction policy and politics in the United States. Harm Reduct J. 2017;14(1):37. doi:10.1186/s12954-017-0157-y.
   Google Scholar
• Soelberg CD , Brown RE Jr , Du Vivier D , Meyer JE , Ramachandran BK . The U.S. opioid crisis: current federal and state legal issues. Anesth Analg. 2017;125(5):1675–1681. doi:10.1213/ANE.0000000000002403.
   Google Scholar
• Potier C , Laprevote V , Dubois-Arber F , Cottencin O , Rolland B . Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48–68. doi:10.1016/j.drugalcdep.2014.10.012.
   Google Scholar
• Kennedy MC , Karamouzian M , Kerr T . Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review. Curr HIV/AIDS Rep. 2017;14(5):161–183. doi:10.1007/s11904-017-0363-y.
   Google Scholar
• Finley EP , Garcia A , Rosen K , McGeary D , Pugh MJ , Potter JS . Evaluating the impact of prescription drug monitoring program implementation: a scoping review. BMC Health Serv Res. 2017;17(1):420. doi:10.1186/s12913-017-2354-5.
   Google Scholar
• Haegerich TM , Paulozzi LJ , Manns BJ , Jones CM . What we know, and don’t know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug Alcohol Depend. 2014;145:34–47. doi:10.1016/j.drugalcdep.2014.10.001.
   Google Scholar